Medicinal Products

Lenalidomid Teva 2,5 mg tvrde kapsule

Name Lenalidomid Teva 2,5 mg tvrde kapsule
Marketing Authorisation Number HR-H-980649384
Active Substance lenalidomidum
Pharmaceutical Form kapsula, tvrda
Strength 2,5 mg
Packaging [MA Number for Packaging] 7 kapsula u blisteru, u kutiji  [HR-H-980649384-01]
7 kapsula u blisteru s jediničnom dozom, u kutiji  [HR-H-980649384-02]
21 kapsula u blisteru, u kutiji  [HR-H-980649384-03]
21 kapsula u blisteru s jediničnom dozom, u kutiji  [HR-H-980649384-04]
Manufacturer Teva UK Ltd., Eastbourne, East Sussex, Ujedinjeno Kraljevstvo
Teva Operations Poland Sp. z o.o., Krakow, Poljska
Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka
Teva Pharma B.V., Haarlem, Nizozemska
Pliva Hrvatska d.o.o., Zagreb, Hrvatska
Marketing Authorisation Holder Teva B.V., Swensweg 5, Haarlem, Nizozemska
Marketing Authorisation Date 27.07.2018
MA Period of Validity 27.07.2023
Classification Number UP/I-530-09/17-01/171
Registration Number 381-12-01/30-18-04
Composition jedna kapsula sadrži lenalidomidklorid hidrat što odgovara 2,5 mg lenalidomida
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code L04AX04
Medicinal product marketed in the Croatia Ne
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Obrazac za prijavu trudnoće, verzija 2
Vodic za zdravstvene radnike, verzija 4
Obrazac pristanka bolesnika, verzija 3
Back